Search

Taiwo Oladapo

Examiner (ID: 13527, Phone: (571)270-3723 , Office: P/1771 )

Most Active Art Unit
1771
Art Unit(s)
1797, 1771
Total Applications
1276
Issued Applications
617
Pending Applications
137
Abandoned Applications
548

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5465001 [patent_doc_number] => 20090325201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Biomarkers for Detection and Diagnosis of Head and Neck Squamous Cell Carcinoma' [patent_app_type] => utility [patent_app_number] => 12/300523 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12177 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325201.pdf [firstpage_image] =>[orig_patent_app_number] => 12300523 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/300523
Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma May 13, 2007 Issued
Array ( [id] => 5230769 [patent_doc_number] => 20070292876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'METHODS FOR IDENTIFICATION OF COMPOUNDS THAT MIMIC THE SENESCENCE-INDUCING ACTIVITY OF RETINOIC ACID RECEPTOR LIGANDS' [patent_app_type] => utility [patent_app_number] => 11/743304 [patent_app_country] => US [patent_app_date] => 2007-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4754 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292876.pdf [firstpage_image] =>[orig_patent_app_number] => 11743304 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/743304
METHODS FOR IDENTIFICATION OF COMPOUNDS THAT MIMIC THE SENESCENCE-INDUCING ACTIVITY OF RETINOIC ACID RECEPTOR LIGANDS May 1, 2007 Abandoned
Array ( [id] => 5210416 [patent_doc_number] => 20070249000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'METHOD FOR DIAGNOSING A PERSON HAVING B-CELL PATHOLOGIES' [patent_app_type] => utility [patent_app_number] => 11/740272 [patent_app_country] => US [patent_app_date] => 2007-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5873 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249000.pdf [firstpage_image] =>[orig_patent_app_number] => 11740272 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/740272
METHOD FOR DIAGNOSING A PERSON HAVING B-CELL PATHOLOGIES Apr 24, 2007 Abandoned
Array ( [id] => 5490849 [patent_doc_number] => 20090291920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'DETECTION OF STEROID RECEPTORS ON CIRCULATING CARCINOMA CELLS AND TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/296458 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7312 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291920.pdf [firstpage_image] =>[orig_patent_app_number] => 12296458 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/296458
DETECTION OF STEROID RECEPTORS ON CIRCULATING CARCINOMA CELLS AND TREATMENT Apr 17, 2007 Abandoned
Array ( [id] => 190593 [patent_doc_number] => 07641903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders' [patent_app_type] => utility [patent_app_number] => 11/735365 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 19 [patent_no_of_words] => 30011 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/641/07641903.pdf [firstpage_image] =>[orig_patent_app_number] => 11735365 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/735365
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders Apr 12, 2007 Issued
Array ( [id] => 5521376 [patent_doc_number] => 20090029357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Method for diagnosing cancer using cancer-associated deletion gene marker' [patent_app_type] => utility [patent_app_number] => 11/783723 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4078 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029357.pdf [firstpage_image] =>[orig_patent_app_number] => 11783723 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/783723
Method for diagnosing cancer using cancer-associated deletion gene marker Apr 10, 2007 Abandoned
Array ( [id] => 5367740 [patent_doc_number] => 20090305299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Method for Determination of Prognosis of Prostate Cancer, and Diagnostic Agent for Use in the Method' [patent_app_type] => utility [patent_app_number] => 12/225998 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3970 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305299.pdf [firstpage_image] =>[orig_patent_app_number] => 12225998 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/225998
Method for determination of prognosis of prostate cancer, and diagnostic agent for use in the method Mar 29, 2007 Issued
Array ( [id] => 4939408 [patent_doc_number] => 20080076727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/693678 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 19104 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076727.pdf [firstpage_image] =>[orig_patent_app_number] => 11693678 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/693678
UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER Mar 28, 2007 Abandoned
Array ( [id] => 4965729 [patent_doc_number] => 20080108549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia' [patent_app_type] => utility [patent_app_number] => 11/731019 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7231 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108549.pdf [firstpage_image] =>[orig_patent_app_number] => 11731019 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/731019
Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia Mar 28, 2007 Abandoned
Array ( [id] => 4802634 [patent_doc_number] => 20080014222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Cancer immunotherapy compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 11/729339 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23415 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014222.pdf [firstpage_image] =>[orig_patent_app_number] => 11729339 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/729339
Cancer immunotherapy compositions and methods of use Mar 27, 2007 Issued
Array ( [id] => 5465000 [patent_doc_number] => 20090325200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'POLYPYRIMIDINE-TRACT BINDING PROTEIN (PTB) AS A BIOMARKER AND TARGET FOR THE DIAGNOSIS AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/293915 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12659 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325200.pdf [firstpage_image] =>[orig_patent_app_number] => 12293915 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/293915
POLYPYRIMIDINE-TRACT BINDING PROTEIN (PTB) AS A BIOMARKER AND TARGET FOR THE DIAGNOSIS AND TREATMENT OF CANCER Mar 22, 2007 Abandoned
Array ( [id] => 5285419 [patent_doc_number] => 20090099094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Use of Somatostatin Agonists to Treat Medullary Thyroid Carcinoma' [patent_app_type] => utility [patent_app_number] => 12/225492 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18621 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099094.pdf [firstpage_image] =>[orig_patent_app_number] => 12225492 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/225492
Use of Somatostatin Agonists to Treat Medullary Thyroid Carcinoma Mar 22, 2007 Abandoned
Array ( [id] => 4710658 [patent_doc_number] => 20080299184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Anticancer agent' [patent_app_type] => utility [patent_app_number] => 11/723694 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9927 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299184.pdf [firstpage_image] =>[orig_patent_app_number] => 11723694 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/723694
Anticancer agent Mar 20, 2007 Issued
Array ( [id] => 6254627 [patent_doc_number] => 20100028914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'ASSESSING LUNG NODULES' [patent_app_type] => utility [patent_app_number] => 12/293318 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4477 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028914.pdf [firstpage_image] =>[orig_patent_app_number] => 12293318 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/293318
ASSESSING LUNG NODULES Mar 15, 2007 Abandoned
Array ( [id] => 5538698 [patent_doc_number] => 20090220503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'METHOD FOR TREATING CANCERS WITH INCREASED RAS SIGNALING' [patent_app_type] => utility [patent_app_number] => 12/282432 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22635 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220503.pdf [firstpage_image] =>[orig_patent_app_number] => 12282432 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/282432
METHOD FOR TREATING CANCERS WITH INCREASED RAS SIGNALING Mar 11, 2007 Abandoned
Array ( [id] => 5309779 [patent_doc_number] => 20090017060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Cleavable Vaccine Compositions and Uses Thereof and Methods of Making and Using the Same' [patent_app_type] => utility [patent_app_number] => 12/281229 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16460 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017060.pdf [firstpage_image] =>[orig_patent_app_number] => 12281229 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/281229
Cleavable vaccine compositions and uses thereof and methods of making and using the same Mar 8, 2007 Issued
Array ( [id] => 5354698 [patent_doc_number] => 20090186042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/280389 [patent_app_country] => US [patent_app_date] => 2007-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 36164 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186042.pdf [firstpage_image] =>[orig_patent_app_number] => 12280389 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/280389
IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER Feb 26, 2007 Abandoned
Array ( [id] => 5367166 [patent_doc_number] => 20090304725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Vaccine and Antigen Mimotopes Against Cancerous Diseases Associated with the Carcinoembryonic Antigen CEA' [patent_app_type] => utility [patent_app_number] => 12/278343 [patent_app_country] => US [patent_app_date] => 2007-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4429 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304725.pdf [firstpage_image] =>[orig_patent_app_number] => 12278343 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/278343
Vaccine and Antigen Mimotopes Against Cancerous Diseases Associated with the Carcinoembryonic Antigen CEA Feb 4, 2007 Abandoned
Array ( [id] => 5005496 [patent_doc_number] => 20070203067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties' [patent_app_type] => utility [patent_app_number] => 11/656009 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3167 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203067.pdf [firstpage_image] =>[orig_patent_app_number] => 11656009 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/656009
Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties Jan 21, 2007 Issued
Array ( [id] => 5095559 [patent_doc_number] => 20070117168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Perinucleolar compartment as a cancer marker' [patent_app_type] => utility [patent_app_number] => 11/651733 [patent_app_country] => US [patent_app_date] => 2007-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8800 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117168.pdf [firstpage_image] =>[orig_patent_app_number] => 11651733 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/651733
Perinucleolar compartment as a cancer marker Jan 9, 2007 Issued
Menu